Avantax Advisory Services’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-263
Closed -$2.02K 1557
2022
Q4
$2.02K Sell
263
-3,811
-94% -$44.1K ﹤0.01% 1418
2022
Q3
$55K Buy
4,074
+823
+25% +$41.6K ﹤0.01% 1296
2022
Q2
$798K Buy
3,251
+77
+2% +$21.7K 0.01% 613
2022
Q1
$924K Buy
3,174
+67
+2% +$16.3K 0.01% 564
2021
Q4
$654K Buy
3,107
+11
+0.4% +$3.02K 0.01% 667
2021
Q3
$1.01M Sell
3,096
-12
-0.4% -$3.73K 0.02% 486
2021
Q2
$1.09M Buy
3,108
+286
+10% +$93.6K 0.02% 454
2021
Q1
$1.08M Buy
+2,822
New +$1.22M 0.02% 412

Other funds holding CFRX

Avantax Advisory Services's CFRX Position: Q1 2023 in Review

Avantax Advisory Services sold out of ContraFect Corporation (CFRX) in Q1 2023, closing a stake of 263 shares — an estimated $2.02K sold.

Avantax Advisory Services first reported a position in CFRX in Q1 2021 and held it in 8 quarters. The position peaked at $1.09M in Q2 2021. 19 funds tracked by Wall St. Rank hold CFRX as of Q1 2023.

  • Avantax Advisory Services reported no remaining ContraFect Corporation position as of Q1 2023 after selling out during the quarter.
  • Avantax Advisory Services sold 263 ContraFect Corporation shares in Q1 2023, an estimated $2.02K.
  • Avantax Advisory Services first reported a position in ContraFect Corporation in Q1 2021 and held it in 8 quarters.
  • Avantax Advisory Services's ContraFect Corporation position peaked at $1.09M in Q2 2021.
  • 19 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2023.

Based on Avantax Advisory Services's 13F filing for Q1 2023, filed 28 Apr 2023.